News

Eli Lilly and Company and MiNA Therapeutics Limited, a pioneer in RNA activation therapeutics, announced a global research collaboration to develop novel drug candidates using MiNA's…
Read More...

Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce today a further expansion of its Highly Potent Active Pharmaceutical…
Read More...

PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second…
Read More...

Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a…
Read More...

Inscopix Inc. a leading neurotechnology company in California that empowers breakthroughs in brain science announced the signing of a distribution agreement with Animalab, a prominent…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company announces that NP-120 (Ifenprodil) reduced interleukin 6 (IL-6) with statistical significance in its…
Read More...

Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, announced that it has begun a global innovation partnership with…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, announced that the U.S. Food and…
Read More...

Neuroscientists at Northwell Health’s Institute for Neurology and Neurosurgery and The Feinstein Institutes for Medical Research will conduct a multi-centered, randomized, Phase 3…
Read More...

Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, a biotech company developing an innovative drug delivery platform…
Read More...

X-Chem, the industry-leading provider of DNA-encoded library (DEL)-based discovery services, announced the global launch of its OpenDEX solution. This new offering provides flexible…
Read More...

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

The U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19)…
Read More...

Fore Biotherapeutics (formerly NovellusDx), a precision oncology company focused on providing people with rare cancer mutations rapid access to the right medicines, announced that it is…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include…
Read More...

OntoChem GmbH, a German Life Science IT company, announced that it has assigned its drug discovery technologies and assets, including its drug discovery collaboration with Anixa…
Read More...

Cambrex announced an expansion of cGMP analytical testing capabilities at its site in Longmont, Colorado. Existing space at the site has been repurposed with cutting edge technologies…
Read More...

BeiGene, Ltd. a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that its PARP inhibitor pamiparib has received…
Read More...

ITM AG, a leading radiopharmaceutical company, announced the establishment of a Chinese subsidiary, ITM (Shanghai) Precision Medical Co., Ltd., in Shanghai, China. The new subsidiary…
Read More...

Pfizer Inc. and BioNTech SE announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate doses of the companies’ COVID-19…
Read More...